Published: 24-09-2024
Review
WASOG 2023 conference highlights
Abstract 168 | PDF Downloads 2Page e2024045
Inhaled budesonide and pulmonary sarcoidosis revisited
Abstract 231 | PDF Downloads 169Page e2024037
Echocardiographic evaluation of left ventricular mechanics in sarcoidosis patients without overt heart disease: a systematic review and meta-analysis
Abstract 193 | PDF Downloads 150Page e2024042
Original Articles: Clinical Research
Scar sarcoidosis: Clinical features and prognostic significance
Abstract 203 | PDF Downloads 142Page e2024046
Central Nervous System Sarcoidosis: A National-Based registry study
Abstract 203 | PDF Downloads 158Page e2024040
Hydroxychloroquine monotherapy in sarcoidosis: Indications, efficacy, and side effects
Abstract 252 | PDF Downloads 179Page e2024039
Are the gains from pulmonary rehabilitation the same in idiopathic pulmonary fibrosis and other interstitial lung diseases?
Abstract 320 | PDF Downloads 310Page e2024038
Interstitial Lung Disease in Primary Sjögren’s Syndrome: Risk factors for occurrence and radiographic progression
Abstract 284 | PDF Downloads 238Page e2024035
The management of Familial Pulmonary Fibrosis in different medical settings: Where does that leave us? An Italian nationwide survey
Abstract 283 | PDF Downloads 189Page e2024047
Assessment of quality of life in IPF Patients: a multicenter observational study
Abstract 220 | PDF Downloads 158Page e2024043
Original Articles: Laboratory Research
Schisandrin B attenuates bleomycin-induced pulmonary fibrosis in mice through AKT-mTOR pathway
Abstract 190 | PDF Downloads 143Page e2024034
Letter to Editor
The fissural involvement in pleuroparenchymal fibroelastosis: Something beyond the alveolar elastosis
Abstract 135 | PDF Downloads 111Page e2024041
Case Reports
Case of familial interstitial lung disease attributed to ATP-binding cassette transporter 3 gene mutation in identical twins
Abstract 188 | PDF Downloads 246Page e2024033